Market Research Life Sciences Market Research Medical Devices Market Research Implantable Devices Market Research

Implantable Cardiac Monitors Market By Indication (Cardiac Arrrythmias, Atrial Fribrillation, Epilepsy And Unexplained Falls), By End User (Hospitals And Clinics, Home Settings, Ambulatory Surgical Centers (Ascs)): Global Opportunity Analysis and Industry

Best Price Guarantee Length Publisher Published Date SKU
from $3,840 115 Pages Allied Market Research March, 2022 ALMR17334380
Best Price Guarantee
Price from $3,840
Length 115 Pages
Publisher Allied Market Research
Published Date March, 2022
SKU ALMR17334380

Implantable Cardiac Monitors Market By Indication (Cardiac Arrrythmias, Atrial Fribrillation, Epilepsy And Unexplained Falls), By End User (Hospitals And Clinics, Home Settings, Ambulatory Surgical Centers (Ascs)): Global Opportunity Analysis and Industry Forecast, 2020-2030

The global implantable cardiac monitors market was valued at $500.02 million in 2020, and is projected to reach $974.42 million by 2030, registering a CAGR of 7.2% from 2021 to 2030.

An implantable cardiac monitor(ICM), also known as implantable loop recorder (ILR), is a small monitoring device used to record electrical activity of the heart. The device is embedded under the chest skin of the patient through which the electrical activity of heart is recorded. The device is activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by physicians to analyze and identify abnormal heart rhythm, precisely to monitor patients who are at risk of myocardial infraction and atrial fibrillation.

Longevity offered by this device, implantable nature of this monitor which does not require patient to be admitted to the hospital, and ability of monitoring patient while they perform daily activities drive the growth of the market. Moreover, increase in incidence of patients suffering from atrial fibrillation, prevalence of myocardial infraction, and unhealthy lifestyle contribute toward the growth of the market. However, availability of alternative mode of treatment and inflated cost of this device are the major barriers that hinder the growth of the market. Conversely, increase in awareness among patients about these devices and treatment options for management of cardiac disorders are expected to offer lucrative growth opportunities for market during the forecast period.

The global ICMs market is segmented on the basis of indication, end user, and region. According to indication, it is categorized into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. Depending on end user, it is classified into hospitals, cardiac centers & clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the ICMs market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Market Segments

By Indication

Cardiac Arrrythmias
Atrial Fribrillation
Epilepsy And Unexplained Falls

By End User

Ambulatory Surgical Centers (Ascs)
Hospitals And Clinics
Home Settings

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Africa
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

ABBOTT LABORATORIES
Boston Scientific Corporation
EDWARDS LIFE SCIENCE CORPORATION


CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiac Arrrythmias
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Atrial Fribrillation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Epilepsy And Unexplained Falls
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals And Clinics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Home Settings
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Ambulatory Surgical Centers (Ascs)
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Indication
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Indication
6.2.4.1.2 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Indication
6.2.4.2.2 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Indication
6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Indication
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Indication
6.3.4.1.2 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Indication
6.3.4.2.2 Market size and forecast, by End User
6.3.4.3 United Kingdom
6.3.4.3.1 Market size and forecast, by Indication
6.3.4.3.2 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Indication
6.3.4.4.2 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Indication
6.3.4.5.2 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Indication
6.3.4.6.2 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Indication
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Indication
6.4.4.1.2 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Indication
6.4.4.2.2 Market size and forecast, by End User
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Indication
6.4.4.3.2 Market size and forecast, by End User
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Indication
6.4.4.4.2 Market size and forecast, by End User
6.4.4.5 South Africa
6.4.4.5.1 Market size and forecast, by Indication
6.4.4.5.2 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Indication
6.4.4.6.2 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Indication
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Indication
6.5.4.1.2 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Indication
6.5.4.2.2 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Indication
6.5.4.3.2 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Indication
6.5.4.4.2 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 ABBOTT LABORATORIES
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Boston Scientific Corporation
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 EDWARDS LIFE SCIENCE CORPORATION
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 2. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR CARDIAC ARRRYTHMIAS, BY REGION , 2020-2030,($MILLION)
TABLE 3. IMPLANTABLE CARDIAC MONITORS MARKET CARDIAC ARRRYTHMIAS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR ATRIAL FRIBRILLATION, BY REGION , 2020-2030,($MILLION)
TABLE 5. IMPLANTABLE CARDIAC MONITORS MARKET ATRIAL FRIBRILLATION BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR EPILEPSY AND UNEXPLAINED FALLS, BY REGION , 2020-2030,($MILLION)
TABLE 7. IMPLANTABLE CARDIAC MONITORS MARKET EPILEPSY AND UNEXPLAINED FALLS BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 9. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 10. IMPLANTABLE CARDIAC MONITORS MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR HOME SETTINGS, BY REGION , 2020-2030,($MILLION)
TABLE 12. IMPLANTABLE CARDIAC MONITORS MARKET HOME SETTINGS BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. IMPLANTABLE CARDIAC MONITORS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION , 2020-2030,($MILLION)
TABLE 14. IMPLANTABLE CARDIAC MONITORS MARKET AMBULATORY SURGICAL CENTERS (ASCS) BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 16. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 17. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 18. NORTH AMERICA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 20. U.S. IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 21. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 22. CANADA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 23. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 24. MEXICO IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 25. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 26. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 27. EUROPE IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 28. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 29. GERMANY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 30. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 31. FRANCE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 32. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 33. UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 34. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 35. ITALY IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 36. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 37. SPAIN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 38. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 39. REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 42. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 43. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 44. JAPAN IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 45. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 46. CHINA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 48. AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 49. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 50. INDIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 52. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 53. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 54. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY INDICATION, 2020-2030,($MILLION)
TABLE 56. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 57. LAMEA IMPLANTABLE CARDIAC MONITORS MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 58. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 59. BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 61. SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 62. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 63. SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 64. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY INDICATION 2020-2030,($MILLION)
TABLE 65. REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET BY END USER 2020-2030,($MILLION)
TABLE 66.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 67.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 68.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 69.ABBOTT LABORATORIES: NET SALES,
TABLE 70.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 71.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 72.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 73.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 74.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 75.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 76.EDWARDS LIFE SCIENCE CORPORATION: COMPANY SNAPSHOT
TABLE 77.EDWARDS LIFE SCIENCE CORPORATION: OPERATING SEGMENTS
TABLE 78.EDWARDS LIFE SCIENCE CORPORATION: PRODUCT PORTFOLIO
TABLE 79.EDWARDS LIFE SCIENCE CORPORATION: NET SALES,
TABLE 80.EDWARDS LIFE SCIENCE CORPORATION: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.IMPLANTABLE CARDIAC MONITORS MARKET SEGMENTATION
FIGURE 2.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
FIGURE 3.IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.IMPLANTABLE CARDIAC MONITORS MARKET,BY INDICATION,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF CARDIAC ARRRYTHMIAS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ATRIAL FRIBRILLATION IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EPILEPSY AND UNEXPLAINED FALLS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 15.IMPLANTABLE CARDIAC MONITORS MARKET,BY END USER,2020(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HOME SETTINGS IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS (ASCS) IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030(%)
FIGURE 19.IMPLANTABLE CARDIAC MONITORS MARKET BY REGION,2020
FIGURE 20.U.S. IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 21.CANADA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 22.MEXICO IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 23.GERMANY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 24.FRANCE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 25.UNITED KINGDOM IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 26.ITALY IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 27.SPAIN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 28.REST OF EUROPE IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 29.JAPAN IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 30.CHINA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 31.AUSTRALIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 32.INDIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 33.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 35.BRAZIL IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 36.SAUDI ARABIA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 37.SOUTH AFRICA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 38.REST OF LAMEA IMPLANTABLE CARDIAC MONITORS MARKET,2020-2030($MILLION)
FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 43.COMPETITIVE DASHBOARD
FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 46.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 47.EDWARDS LIFE SCIENCE CORPORATION.: NET SALES ,($MILLION)

$5,769
$3,840
$6,450
$10,995

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings